Preventing cervical cancer in the United States: Barriers and resolutions for HPV vaccination

Frontiers in Oncology

Volumn 6, Issue FEB, 2016, Pages

  Beavis, Anna Louise ^a   Levinson, Kimberly L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Cervical cancer; Disparities; Health policy; HPV; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; VIRUS VACCINE; WART VIRUS VACCINE;

COUNSELING; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; LEGAL ASPECT; META ANALYSIS (TOPIC); PARENTAL ATTITUDE; RACE; REVIEW; SEXUAL BEHAVIOR; SEXUAL ORIENTATION; SOCIOECONOMICS; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION;

EID: 84964459857     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2016.00019     Document Type: Review

References (64)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin (2015) 65(1):5-29. doi:10.3322/caac.21254
2. Simard EP, Naishadham D, Saslow D, Jemal A. Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol Oncol (2012) 127(3):611-5. doi:10.1016/j.ygyno.2012.08.021
3. Schiller JT, Castellsagué X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine (2008) 26(Suppl 1):K53-61. doi:10.1016/j.vaccine.2008.06.002
4. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 63(RR-05):1-30
5. Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med (2015) 372(8):711-23. doi:10.1056/NEJMoa1405044
6. Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep (2015) 64(11):300-4
7. Schmidt S, Parsons HM. Vaccination interest and trends in human papillomavirus vaccine uptake in young adult women aged 18 to 26 years in the United States: an analysis using the 2008-2012 National Health Interview Survey. Am J Public Health (2014) 104(5):946-53. doi:10.2105/AJPH.2013.301828
8. Garland SM. The Australian experience with the human papillomavirus vaccine. Clin Ther (2014) 36(1):17-23. doi:10.1016/j.clinthera.2013.12.005
9. Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ (2013) 346:f2032. doi:10.1136/bmj.f2032
10. CDC-Teen Vaccination Coverage-NIS-Teen-Vaccines (2015). Available from: http://www.cdc.gov/vaccines/who/teens/vaccination-coverage.html
11. Healthy People 2020 Topics and Objectives: Immunization and Infectious Diseases (2015). Available from: http://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives?topicId=23
12. Grant SR, Walker GV, Guadagnolo BA, Koshy M, Allen PK, Mahmood U. Variation in insurance status by patient demographics and tumor site among nonelderly adult patients with cancer. Cancer (2015) 121(12):2020-8. doi:10.1002/cncr.29120
13. Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Changing demographics of cervical cancer in the United States (1973-2008). Gynecol Oncol (2012) 126(3):330-3. doi:10.1016/j.ygyno.2012.05.035
14. Rositch AF, Nowak RG, Gravitt PE. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer (2014) 120(13):2032-8. doi:10.1002/cncr.28548
15. Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2014. MMWR Morb Mortal Wkly Rep (2014) 64(29):784-92. doi:10.15585/mmwr.mm6429a3
16. Kramer MR, Dunlop AL. Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007. Matern Child Health J (2012) 16(Suppl 1):S102-10. doi:10.1007/s10995-012-0999-6
17. Agénor M, Peitzmeier S, Gordon AR, Haneuse S, Potter JE, Austin SB. Sexual orientation identity disparities in awareness and initiation of the human papillomavirus vaccine among U.S. women and girls. Ann Intern Med (2015) 163(2):99. doi:10.7326/M14-2108
18. McRee A-L, Katz ML, Paskett ED, Reiter PL. HPV vaccination among lesbian and bisexual women: findings from a national survey of young adults. Vaccine (2014) 32(37):4736-42. doi:10.1016/j.vaccine.2014.07.001
19. Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol (2013) 42(3):896-908. doi:10.1093/ije/dyt049
20. Sudenga SL, Royse KE, Shrestha S. Role and uptake of human papillomavirus vaccine in adolescent health in the United States. Adolesc Health Med Ther (2011) 2011(2):63-74. doi:10.2147/AHMT.S15941
21. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics (2010) 126(3):425-33. doi:10.1542/peds.2009-3500
22. Moss JL, Reiter PL, Brewer NT. Correlates of human papillomavirus vaccine coverage: a state-level analysis. Sex Transm Dis (2015) 42(2):71-5. doi:10.1097/OLQ.0000000000000225
23. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2008. MMWR Morb Mortal Wkly Rep (2009) 58(36):997-1001
24. Ladner J, Besson M-H, Rodrigues M, Audureau E, Saba J. Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013. BMC Public Health (2014) 14:670. doi:10.1186/1471-2458-14-670
25. Steinau M, Hariri S, Gillison ML, Broutian TR, Dunne EF, Tong ZY, et al. Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis (2014) 209(11):1739-43. doi:10.1093/infdis/jit799
26. Lefkowitz ES, Kelly KM, Vasilenko SA, Maggs JL. Correlates of human papillomavirus vaccination among female university students. Women Health (2014) 54(6):487-501. doi:10.1080/03630242.2014.903552
27. Laz TH, Rahman M, Berenson AB. Human papillomavirus vaccine uptake among 18-to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer (2013) 119(7):1386-92. doi:10.1002/cncr.27894
28. Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health (2001) 91(6):947-52. doi:10.2105/AJPH.91.6.947
29. Agénor M, Krieger N, Austin SB, Haneuse S, Gottlieb BR. Sexual orientation disparities in Papanicolaou test use among US women: the role of sexual and reproductive health services. Am J Public Health (2014) 104(2):e68-73. doi:10.2105/AJPH.2013.301548
30. Johnson SE, Holder-Hayes E, Tessman GK, King BA, Alexander T, Zhao X. Tobacco product use among sexual minority adults: findings from the 2012-2013 National Adult Tobacco Survey. Am J Prev Med (2015). doi:10.1016/j.amepre.2015.07.041
31. Giuliano AR, Sedjo RL, Roe DJ, Harri R, Baldwi S, Papenfuss MR, et al. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control (2002) 13(9):839-46. doi:10.1023/A:1020668232219
32. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst (2002) 94(18):1406-14. doi:10.1093/jnci/94.18.1406
33. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol (2008) 111(5):1103-10. doi:10.1097/AOG.0b013e31817051fa
34. Liddon NC, Hood JE, Leichliter JS. Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth. Vaccine (2012) 30(16):2676-82. doi:10.1016/j.vaccine.2012.02.007
35. U.S. Department of Health and Human Services. The Affordable Care Act and Immunization | HHS.gov (2015). Available from: http://www.hhs.gov/healthcare/facts-and-features/fact-sheets/aca-and-immunization/index.html
36. Wisk LE, Allchin A, Witt WP. Disparities in human papillomavirus vaccine awareness among U.S. parents of preadolescents and adolescents. Sex Transm Dis (2014) 41(2):117-22. doi:10.1097/OLQ.0000000000000086
37. Blake KD, Ottenbacher AJ, Finney Rutten LJ, Grady MA, Kobrin SC, Jacobson RM, et al. Predictors of human papillomavirus awareness and knowledge in 2013: gaps and opportunities for targeted communication strategies. Am J Prev Med (2015) 48(4):402-10. doi:10.1016/j.amepre.2014.10.024
38. Roberts JR, Thompson D, Rogacki B, Hale JJ, Jacobson RM, Opel DJ, et al. Vaccine hesitancy among parents of adolescents and its association with vaccine uptake. Vaccine (2015) 33(14):1748-55. doi:10.1016/j.vaccine.2015.01.068
39. Krawczyk A, Perez S, King L, Vivion M, Dubé E, Rosberger Z. Parents' decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative results. Hum Vaccin Immunother (2015) 11(2):330-6. doi:10.4161/21645515.2014.980708
40. Perkins RB, Clark JA, Apte G, Vercruysse JL, Sumner JJ, Wall-Haas CL, et al. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics (2014) 134(3):e666-74. doi:10.1542/peds.2014-0442
41. Markovitz AR, Song JY, Paustian ML, El Reda DK. Association between maternal preventive care utilization and adolescent vaccination: it's not just about Pap testing. J Pediatr Adolesc Gynecol (2014) 27(1):29-36. doi:10.1016/j.jpag.2013.08.012
42. Monnat SM, Wallington SF. Is there an association between maternal pap test use and adolescent human papillomavirus vaccination? J Adolesc Health (2013) 52(2):212-8. doi:10.1016/j.jadohealth.2012.05.015
43. Gerend MA, Shepherd MA, Lustria MLA. Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women's perceived barriers. Sex Transm Dis (2013) 40(5):401-5. doi:10.1097/OLQ.0b013e318283c8a8
44. Ratanasiripong NT, Cheng A-L, Enriquez M. What college women know, think, and do about human papillomavirus (HPV) and HPV vaccine. Vaccine (2013) 31(10):1370-6. doi:10.1016/j.vaccine.2013.01.001
45. Mullins TL, Griffioen AM, Glynn S, Zimet GD, Rosenthal SL, Fortenberry JD, et al. Human papillomavirus vaccine communication: perspectives of 11-12 year-old girls, mothers, and clinicians. Vaccine (2013) 31(42):4894-901. doi:10.1016/j.vaccine.2013.07.033
46. Strikas RA. Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years-United States, 2015. MMWR Morb Mortal Wkly Rep (2015) 64(4):93-4
47. Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis (2011) 38(3):197-204. doi:10.1097/OLQ.0b013e3181f12dbf
48. Gargano LM, Herbert NL, Painter JE, Sales JM, Morfaw C, Rask K, et al. Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Hum Vaccin Immunother (2013) 9(12):2627-33. doi:10.4161/hv.25823
49. Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev (2015) 24(11):1673-9. doi:10.1158/1055-9965.EPI-15-0326
50. U.S. Department of Health and Human Services. Prevention and Public Health Fund | HHS.gov (2015). Available from: http://www.hhs.gov/open/prevention/index.html
51. Fu LY, Bonhomme L-A, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine (2014) 32(17):1901-20. doi:10.1016/j.vaccine.2014.01.091
52. Gargano LM, Herbert NL, Painter JE, Sales JM, Vogt TM, Morfaw C, et al. Development, theoretical framework, and evaluation of a parent and teacher-delivered intervention on adolescent vaccination. Health Promot Pract (2014) 15(4):556-67. doi:10.1177/1524839913518222
53. Foley OW, Birrer N, Rauh-Hain JA, Clark RM, DiTavi E, Del Carmen MG. Effect of educational intervention on cervical cancer prevention and screening in Hispanic women. J Community Health (2015) 40(6):1178-84. doi:10.1007/s10900-015-0045-x
54. Bennett AT, Patel DA, Carlos RC, Zochowski MK, Pennewell SM, Chi AM, et al. Human papillomavirus vaccine uptake after a tailored, online educational intervention for female university students: a randomized controlled trial. J Womens Health (Larchmt) (2015) 24(11):950-7. doi:10.1089/jwh.2015.5251
55. U.S. Preventative Services Task Force. The Community Guide-Summary-Vaccination: Standing Orders (2015). Available from: http://www.thecommunityguide.org.ezp.welch.jhmi.edu/vaccines/standingorders.html
56. Dempsey AF, Pyrzanowski J, Brewer S, Barnard J, Sevick C, O'Leary ST. Acceptability of using standing orders to deliver human papillomavirus vaccines in the outpatient obstetrician/gynecologist setting. Vaccine (2015) 33(15):1773-9. doi:10.1016/j.vaccine.2015.02.044
57. Niccolai LM, Hansen CE. Practice-and community-based interventions to increase human papillomavirus vaccine coverage: a systematic review. JAMA Pediatr (2015) 169(7):686-92. doi:10.1001/jamapediatrics.2015.0310
58. Fiks AG, Grundmeier RW, Mayne S, Song L, Feemster K, Karavite D, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics (2013) 131(6):1114-24. doi:10.1542/peds.2012-3122
59. Tiro JA, Sanders JM, Pruitt SL, Stevens CF, Skinner CS, Bishop WP, et al. Promoting HPV vaccination in safety-net clinics: a randomized trial. Pediatrics (2015) 136(5):850-9. doi:10.1542/peds.2015-1563
60. Nodulman JA, Starling R, Kong AS, Buller DB, Wheeler CM, Woodall WG. Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs. J Sch Health (2015) 85(5):289-98. doi:10.1111/josh.12253
61. Daley MF, Kempe A, Pyrzanowski J, Vogt TM, Dickinson LM, Kile D, et al. School-located vaccination of adolescents with insurance billing: cost, reimbursement, and vaccination outcomes. J Adolesc Health (2014) 54(3):282-8. doi:10.1016/j.jadohealth.2013.12.011
62. Pitts MJ, Adams Tufts K. Implications of the Virginia human papillomavirus vaccine mandate for parental vaccine acceptance. Qual Health Res (2013) 23(5):605-17. doi:10.1177/1049732312470871
63. National Conference of State Legislatures. HPV Vaccine: State Legislation and Statutes (2015). Available from: http://www.ncsl.org/research/health/hpv-vaccine-state-legislation-and-statutes.aspx
64. State of Rhode Island Department of Health. Rules and Regulations Pertaining to Immunization and Communicable Disease Testing in Preschool, School, Colleges, and Universities (2014). Available from: http://sos.ri.gov/documents/archives/regdocs/released/pdf/DOH/7602.pdf